Jian Chen

Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Sm

M. Socinski, R. Govindan, R. Hermann, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors

David A. Smith, D. V. Von Hoff, F. Braiteh, 2015, Investigational New Drugs.

Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studies

T. Stinchcombe, I. Okamoto, W. John, 2017, Current medical research and opinion.

Clinical features and prognosis-associated factors of non-small cell lung cancer exhibiting symptoms of bone metastasis at the time of diagnosis.

W. Wang, Jie He, J. Niu, 2015, Oncology letters.

Phase II OVARIO study of niraparib + bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab

Richard O. Moore, H. Gray, G. Konecny, 2020, Gynecologic Oncology.

A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.

Jian Chen, Yifu He, Pingsheng Fan, 2013, World journal of gastroenterology.

Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis

Chaosu Hu, Xiaomao Guo, G. Cai, 2016, Breast Cancer.

Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers

G. Bepler, M. Schell, S. Altiok, 2013, Cancer.

Safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin: a real-world retrospective, observational, cohort study

R. Goodloe, W. John, Lei Chen, 2017, Current medical research and opinion.

Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.

Ke Chen, Wei Wei, W. Jia, 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers

G. Bepler, M. Schell, S. Altiok, 2013, Cancer.

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.

G. Scagliotti, C. Gridelli, A. Wozniak, 2017, Clinical lung cancer.